Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
25.04. | Envoy Medical, Inc. - S-1/A, General form for registration of securities | 1 | SEC Filings | ||
12.04. | Envoy Medical, Inc. - S-8, Securities to be offered to employees in employee benefit plans | 3 | SEC Filings | ||
05.04. | Envoy Medical, Inc. - S-1/A, General form for registration of securities | 1 | SEC Filings | ||
03.04. | Envoy Medical, Inc: Envoy Medical to Participate in the LD Micro Invitational XIV Conference April 8 - 9, 2024 | 1 | GlobeNewswire (USA) | ||
02.04. | Envoy Medical, Inc: Envoy Medical Reports Fourth Quarter and Full Year 2023 Financial Results | 97 | GlobeNewswire (Europe) | Company Provides Corporate Update that Include Updates on its Investigational Fully Implanted Acclaim® Cochlear Implant Meeting its Early Feasibility Study Milestones Recent bipartisan Congressional... ► Artikel lesen | |
01.04. | Envoy Medical, Inc. - 10-K, Annual Report | 1 | SEC Filings | ||
12.03. | Envoy Medical, Inc: Envoy Medical to Participate in the 36th Annual ROTH Conference | 1 | GlobeNewswire (USA) | ||
04.03. | Envoy Medical, Inc: Envoy Medical Secures Up To $10 Million Term Debt Financing to Advance Upcoming Clinical Trial | 2 | GlobeNewswire (USA) | ||
04.03. | Envoy Medical, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
15.02. | Envoy Medical, Inc. - S-1/A, General form for registration of securities | - | SEC Filings | ||
07.02. | Envoy Medical, Inc: Newly Introduced Bipartisan Bill Seeks to Clarify Fully Implanted Active Middle Ear Hearing Devices as Prosthetics, Not Hearing Aids, Making Them Eligible for Medicare Coverage | - | GlobeNewswire (USA) | ||
05.02. | Envoy Medical, Inc: Envoy Medical CEO Brent Lucas Interviewed by Leading Healthcare Podcast Medical Alley | 2 | GlobeNewswire (USA) | ||
30.01. | DealFlow Events: Envoy Medical, Inc. to Present at The Microcap Conference | 352 | Newsfile | White Bear Lake, Minnesota--(Newsfile Corp. - January 30, 2024) - Envoy Medical®, Inc. (NASDAQ: COCH) ("Envoy Medical"), a revolutionary hearing health company focused on fully implanted hearing systems... ► Artikel lesen | |
22.01. | MCRA, LLC: MCRA Provides Anzu Special Acquisition Corp I with Strategic Diligence Support Leading to Envoy Medical Merger (NASDAQ: COCH) | 428 | PR Newswire | WASHINGTON, Jan. 22, 2024 /PRNewswire/ -- MCRA, LLC, a leading medical device and biologics focused clinical research organization (CRO) and advisory firm integrating seven core services [U.S. and... ► Artikel lesen | |
22.01. | Envoy Medical, Inc: Envoy Medical Announces Three Additional Patents for Implantable Cochlear Systems | 2 | GlobeNewswire (USA) | ||
18.01. | Envoy Medical, Inc. - S-1, General form for registration of securities | 7 | SEC Filings | ||
17.01. | Envoy Medical, Inc. - 10-Q/A, Quarterly Report | 1 | SEC Filings | ||
19.12.23 | Envoy Medical, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
04.12.23 | Envoy Medical, Inc: Envoy Medical to Host Fireside Chat Event December 7 | 2 | GlobeNewswire (USA) | ||
20.11.23 | Envoy Medical, Inc: Envoy Medical Provides Third Quarter 2023 Financial Results and Business Update | 488 | GlobeNewswire (Europe) | Interim Findings from Early Feasibility Trial Provide Important Learnings and Feedback Ahead of Pivotal Clinical Trial Planned for 2024 Virtual Fireside Chat to be held December 7 WHITE BEAR LAKE... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
SIEMENS HEALTHINEERS | 51,90 | +1,37 % | EQS-DD: Siemens Healthineers AG: Dr. Bernhard Montag, Kauf von Siemens Healthineers Aktien für einen Betrag von EUR 98.817,91 abzüglich Steuern und Abgaben als automatische Wiederanlage von ... | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
26.04.2024 / 14:49... ► Artikel lesen | |
FRESENIUS | 27,950 | 0,00 % | Fresenius-Aktie leicht im Minus (27,10 €) | Im deutschen Wertpapierhandel liegt das Wertpapier von Fresenius zur Stunde im Minus. Der jüngste Kurs betrug 27,10 Euro. Heute hat sich an der deutschen Börse der Anteilsschein von Fresenius zwischenzeitlich... ► Artikel lesen | |
FRESENIUS MEDICAL CARE | 39,260 | -2,34 % | Aixtron, FMC, LPKF Laser, ProSiebenSat.1 Media, Siemens Energy, Varta und Co. - Aktien-Positionen der Shortseller | Wer Aktien leer verkauft, das sogenannte Shortselling, muss Transparenzpflichten erfüllen. Wir werfen einen Blick auf aktuelle Shortseller-Meldungen. Geregelt sind diese in der EU-Leerverkaufsverordnung... ► Artikel lesen | |
PROCEPT BIOROBOTICS | 64,31 | +4,25 % | PROCEPT BioRobotics Corp - 10-Q, Quarterly Report | ||
CARL ZEISS MEDITEC | 97,80 | +0,46 % | Neue 11,00% Aktienanleihe mit Barriere auf Carl Zeiss Meditec in Zeichnung | München (www.anleihencheck.de) - Die Experten vom Zertifikate-Team der Bank Vontobel Europe AG bieten eine neue Aktienanleihe (ISIN DE000VD4NFC9/ WKN VD4NFC) mit Barriere auf die Aktie von Carl Zeiss... ► Artikel lesen | |
MOBILE-HEALTH NETWORK SOLUTIONS | 3,330 | -84,91 % | Mobile-health Retreats on Opening New Pharmacy | ||
RXSIGHT | 61,68 | +3,44 % | RxSight, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results | ALISO VIEJO, Calif., Feb. 28, 2024 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery... ► Artikel lesen | |
ATRICURE | 20,890 | -5,94 % | AtriCure Reports First Quarter 2024 Financial Results | MASON, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and... ► Artikel lesen | |
GERRESHEIMER | 102,00 | +0,39 % | Eli Lilly fegt die Prognosen vom Tisch - auch Novo Nordisk, Gerresheimer, Gubra und Co springen ... | Der amerikanische Pharma-Riese Eli Lilly hat die hohen Erwartungen der Marktteilnehmer klar übertreffen können. Vor allem der Boom bei Tirzepatid-basierten Produkten (Diabetes-Mittel Mounjaro und "Abnehmspritze"... ► Artikel lesen | |
PRIVIA HEALTH GROUP | 18,740 | +1,79 % | Privia Health Group, Inc.: Privia Health Reports Fourth Quarter and Full-Year 2023 Financial Results | Achieved All 2023 Operating and Financial Guidance MetricsImplemented Providers +19.4% compared to Year-End 2022Introduces Full-Year 2024 GuidanceProactive Steps to Limit Downside Risk Arrangements... ► Artikel lesen | |
BRIGHTSPRING HEALTH SERVICES | 11,500 | +3,98 % | BrightSpring Health Services, Inc. Reports First Quarter 2024 Financial Results and Increases Full Year 2024 Guidance | LOUISVILLE, Ky., May 02, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
CASTLE BIOSCIENCES | 24,330 | +6,24 % | Castle Biosciences Reports First Quarter 2024 Results | FRIENDSWOOD, Texas--(BUSINESS WIRE)--Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced its financial results... ► Artikel lesen | |
ALIGNMENT HEALTHCARE | 6,630 | +25,33 % | Alignment Healthcare Reports First Quarter 2024 Results | Reports $628.6 million in total revenue and $627.6 million in revenue excluding ACO REACH, up 43.1% and 54.2% year-over-year respectivelyMedicare Advantage membership grows 50.5% year-over-year to... ► Artikel lesen | |
MIMEDX | 7,370 | -1,73 % | MiMedx Group, Inc: MIMEDX Announces First Quarter 2024 Operating and Financial Results | Net Sales of $85 Million Grew 18% Year-Over-Year for the First Quarter First Quarter GAAP Net Income was $9 Million First Quarter Adjusted EBITDA of $19 Million, or 22% of Net Sales Management... ► Artikel lesen | |
PROGYNY | 31,710 | -1,12 % | Progyny, Inc. Announces Third Quarter 2023 Results | Record Quarterly Revenue of $280.9 Million, Reflecting 37% Growth Over the Prior Year PeriodRaises Full Year Revenue and Earnings GuidanceStrong Sales Season Produces 1.3 Million New Covered Lives... ► Artikel lesen |